Vanessa Raymont
MBChB MSc MRCPsych
Senior Clinical Researcher, R&D Director Oxford Health NHS Foundation Trust
- Honorary Senior Clinical Research Fellow, Centre of Dementia Prevention, University of Edinburgh
- Honorary Consultant Psychiatrist
My clinical and research interests are in traumatic brain injury, and memory disorders and dementia, as well as clinical trials in cognitive impairment, having worked for over 20 years in clinical trials in the UK and US.
I am currently the Principal Investigator for the New Therapeutics in Alzheimer’s Disease (NTAD), Brains for Dementia Research (BDR) and 7Tesla MRI Scanning in Alzheimer’s disease and Frontotemporal Lobar Degeneration studies and Chief Investigator on the Deep and Frequent Phenotyping (DFP) study and a NHIR-funded study assessing the use of sertraline to prevent post-head injury depression. I am co-lead for the Clinical Trials section of Oxford Translational Neuroscience and Dementia Research Group and NIHR Dementia and Mental Health Lead for the Thames Valley and South Midlands Clinical Research Network. I am an associate director of Dementia Platforms UK, and workstream lead for the Trials Delivery Framework. I serve as a Commissioner for the Commission on Human Medicines.
Recent publications
-
Journal article
Blane J. et al, (2021), Alzheimers Dement, 17 Suppl 11
-
Journal article
Lennon MJ. et al, (2021), J Alzheimers Dis
-
Journal article
Delanerolle G. et al, (2021), EClinicalMedicine, 38
-
Journal article
Burns DK. et al, (2021), The Lancet Neurology, 20, 537 - 547
-
Journal article
Phiri P. et al, (2021), EClinicalMedicine, 34
-
History for some or lesson for all? A systematic review and meta-analysis on the immediate and long-term mental health impact of the 2002-2003 Severe Acute Respiratory Syndrome (SARS) outbreak
Journal article
Chau S. et al, (2021), BMC Public Health
-
Journal article
Delanerolle G. et al, (2021), World J Psychiatry, 11, 58 - 62
-
Journal article
Baksh RA. et al, (2021), Psychol Aging, 36, 288 - 297
-
Journal article
Delanerolle G. et al, (2021), British Journal of Neuroscience Nursing, 17, 13 - 16
-
Journal article
Delanerolle G. et al, (2021), Womens Health (Lond), 17
-
Journal article
Delanerolle G. et al, (2021), Womens Health (Lond), 17
-
Journal article
Mendis SB. et al, (2021), Front Neurol, 12
-
Conference paper
Hapangama D. et al, (2020), INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 30, A52 - A53
-
Journal article
Calvin CM. et al, (2020), Alzheimers Res Ther, 12
-
Journal article
Raymont V. and Thayanandan T., (2020), Minerva Med
-
Journal article
Pardini M. et al, (2020), CNS Spectr, 25, 24 - 31
-
Journal article
Goel V. et al, (2019), J Cogn Neurosci, 31, 1674 - 1688
-
Partnership in practice: an innovative Brain Health Centre
Conference paper
O'DONOGHUE M. et al, (2019)
-
Journal article
Koychev I. et al, (2019), BMJ Open, 9
-
Journal article
Jolly AE. et al, (2019), Neuroimage Clin, 24
-
Journal article
Eimontaite I. et al, (2018), Neuropsychologia, 119, 320 - 329
-
Journal article
Mueller C. et al, (2018), International Journal of Therapy and Rehabilitation, 25, 107 - 119
-
Journal article
Robert Brašić J. et al, (2018), Int J Phys Med Rehabil, 6
-
A preliminary report about the psychological effects of dopamine on people with the syndrome of Gilles de la Tourette. report about the psychological effects of dopamine on people with the syndrome of Gilles de la Tourette
Conference paper
Brasic J. et al, (2017), JOURNAL OF NUCLEAR MEDICINE, 58
-
Journal article
Goel V. et al, (2017), Neuropsychologia, 99, 236 - 245
-
Journal article
Mueller C. et al, (2017), Brain Inj, 31, 1863 - 1870
-
Journal article
Paradiso S. et al, (2016), J Clin Exp Neuropsychol, 38, 887 - 899
-
Journal article
Greenan C. et al, (2016), Trials, 17
-
Journal article
Huey ED. et al, (2016), J Neuropsychiatry Clin Neurosci, 28, 104 - 111
-
Journal article
Lewis JD. et al, (2015), Brain Imaging Behav, 9, 456 - 460
-
Journal article
Davis RE. et al, (2015), Psychopharmacology (Berl), 232, 2863 - 2872
-
Journal article
Knutson KM. et al, (2015), J Neuropsychiatry Clin Neurosci, 27, 193 - 198
-
Journal article
Pardini M. et al, (2014), CNS Spectr, 19, 382 - 390
-
Journal article
Schneider EB. et al, (2014), Neurology, 82, 1636 - 1642
-
Journal article
Knutson KM. et al, (2014), Hum Brain Mapp, 35, 943 - 953
-
Journal article
Wong D. et al, (2014), Neuropsychopharmacology, 39
-
Chapter
Horti AG. et al, (2014), PET and SPECT of Neurobiological Systems, 249 - 319
-
Journal article
Owen GS. et al, (2013), Br J Psychiatry, 203, 461 - 467
-
Journal article
Dal Monte O. et al, (2013), Soc Cogn Affect Neurosci, 8, 632 - 639
-
Journal article
Wong DF. et al, (2013), Neuroimage, 75, 282 - 290
-
Journal article
Glass L. et al, (2013), Cereb Cortex, 23, 1663 - 1672
-
Reduced dopamine blockade in the basal ganglia in obsessive-compulsive disorder
Conference paper
Brasic J. et al, (2013), JOURNAL OF NUCLEAR MEDICINE, 54
-
Journal article
Rosenberg PB. et al, (2013), Am J Geriatr Psychiatry, 21, 272 - 278
-
Journal article
Knutson KM. et al, (2013), Neuropsychologia, 51, 686 - 694
-
Journal article
Folio L. et al, (2013), Mil Med, 178, 338 - 345
-
Journal article
Martin-Facklam M. et al, (2013), Neuropsychopharmacology, 38, 504 - 512
-
Journal article
Waechter RL. et al, (2013), Neuropsychologia, 51, 464 - 471
-
Journal article
Raymont V. et al, (2013), New Journal of Chemistry, 37, 893 - 900
-
Dopamine release and serotonin interactions in Tourette's syndrome: new relations to obsessive compulsive disorder
Conference paper
Wong DF. et al, (2012), JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 32, S96 - S97
-
Effects of amphetamine-induced dopamine release and raclopride-induced dopamine blockade on psychiatric symptoms and tics of subjects with and without Gilles de la Tourette syndrome
Conference paper
Brasic JR. et al, (2012), JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 32, S92 - S92
-
Correlation of psychiatric symptoms and tics with amphetamine-induced dopamine release (DAR) in the striata of people with Gilles de la Tourette syndrome (TS) and obsessive-compulsive disorder (OCD)
Conference paper
Brasic J. et al, (2012), JOURNAL OF NUCLEAR MEDICINE, 53
-
Imaging biomarkers for the glycine transporter type 1
Conference paper
Wong D. et al, (2012), JOURNAL OF NUCLEAR MEDICINE, 53
-
Cannabinoid Receptor Subtype 1 (CB1) Distribution Correlates with Neuropsychiatric Ratings
Conference paper
Wong DF. et al, (2012), BIOLOGICAL PSYCHIATRY, 71, 258S - 258S
-
Journal article
Brašić JR. et al, (2012), Synapse, 66, 352 - 368
-
Journal article
Pardini M. et al, (2012), Transl Psychiatry, 2
-
Journal article
Knutson KM. et al, (2012), Cogn Neurosci, 3, 131 - 138
-
Cannabinoid receptor subtype 1 (CB1) distribution and neuropsychiatric ratings
Conference paper
Wong D. et al, (2011), JOURNAL OF NUCLEAR MEDICINE, 52
-
Differences in dopamine release in Tourette's syndrome and obsessive-compulsive disorder
Conference paper
Wong D. et al, (2011), JOURNAL OF NUCLEAR MEDICINE, 52
-
Partial remission of Gilles de la Tourette syndrome in a 24-year-old man after heat-induced dehydration
Conference paper
Brasic JR. et al, (2011), MOVEMENT DISORDERS, 26, S368 - S368
-
Journal article
Pardini M. et al, (2011), Neurology, 76, 1038 - 1045
-
Journal article
Krueger F. et al, (2011), J Neurosci, 31, 598 - 606
-
Journal article
Raymont V. et al, (2011), Front Neurol, 2
-
Journal article
Rostami E. et al, (2011), PLoS One, 6
-
Journal article
Wong DF. et al, (2010), Neuroimage, 52, 1505 - 1513
-
Conference paper
Wong DF. et al, (2010), NEUROIMAGE, 52, S11 - S12
-
Conference paper
Wong DF. et al, (2010), NEUROIMAGE, 52, S64 - S64
-
Conference paper
Kuwabara H. et al, (2010), NEUROIMAGE, 52, S185 - S185
-
Journal article
Raymont V. et al, (2010), Neurology, 75, 224 - 229
-
Journal article
Wong DF. et al, (2010), J Nucl Med, 51, 913 - 920
-
STRIATAL DOPAMINE RELEASE IS COMPROMISED IN ALCOHOL-DEPENDENT SUBJECTS
Conference paper
Wong DF. et al, (2010), ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 34, 256A - 256A
-
Identification of region specific occupancy of mu-opioid receptors by fixed dose naltrexone in alcohol dependent subjects
Conference paper
Kuwabara H. et al, (2010), JOURNAL OF NUCLEAR MEDICINE, 51
-
Quantification of cerebral cannabinoid receptors subtype 1 (CB1) in healthy subjects and schizophrenia by the novel PET radioligand [C-11]OMAR
Conference paper
Wong D. et al, (2010), JOURNAL OF NUCLEAR MEDICINE, 51
-
Journal article
Pardini M. et al, (2010), Neurology, 74, 749 - 754
-
AN IN VIVO POSITRON EMISSION TOMOGRAPHY STUDY OF THE CB1 OCCUPANCY BY AVE1625 USING [C-11]-JHU75528 IN HEALTHY SUBJECTS AND IN PATIENTS WITH SCHIZOPHRENIA.
Conference paper
Ming JE. et al, (2010), CLINICAL PHARMACOLOGY & THERAPEUTICS, 87, S67 - S67
-
Journal article
Krueger F. et al, (2009), Proc Natl Acad Sci U S A, 106, 22486 - 22491
-
Journal article
Gozzi M. et al, (2009), Neuropsychologia, 47, 2125 - 2132
-
PET IMAGING OF CANNABINOID RECEPTORS IN SCHIZOPHRENIA
Conference paper
Wong DF. et al, (2009), SCHIZOPHRENIA BULLETIN, 35, 172 - 172
-
Journal article
Koenigs M. et al, (2008), J Neurosci, 28, 12341 - 12348
-
Journal article
Frangou S. et al, (2008), Eur Psychiatry, 23, 300 - 308
-
Journal article
Raymont V. et al, (2008), Brain, 131, 543 - 558
-
Journal article
Koenigs M. et al, (2008), Nat Neurosci, 11, 232 - 237
-
Conference paper
Wong DF. et al, (2008), NEUROIMAGE, 41, T51 - T51
-
Journal article
Solomon J. et al, (2007), Comput Methods Programs Biomed, 86, 245 - 254
-
Predictors of capacity among inpatients: A UK perspective
Conference paper
Anthony DS. et al, (2007), SCHIZOPHRENIA BULLETIN, 33, 510 - 510
-
Journal article
Raymont V. et al, (2007), Int J Law Psychiatry, 30, 112 - 117
-
Journal article
Raymont V. and Grafman J., (2006), REPROGRAMMING THE BRAIN, 157, 199 - 206
-
Journal article
Raymont V. and Grafman J., (2006), Prog Brain Res, 157, 199 - 206
-
Journal article
Hotopf M. and Raymont V., (2005), Foundation Years, 1, 18 - 20
-
Mental capacity of inpatients - Reply
Journal article
Hotopf M. et al, (2005), LANCET, 365, 569 - 569
-
Journal article
O'Keeffe ST., (2005), Lancet, 365, 568 - 569
-
Journal article
Raymont V. et al, (2004), Lancet, 364, 1421 - 1427
-
Journal article
Hotopf M. and Raymont V., (2004), Psychiatry, 3, 8 - 10
-
Journal article
Hudson SA. and Raymont V., (2004), British Journal of Psychiatry, 184, 84 - 85
-
Journal article
Hudson SA. and Raymont V., (2004), Br J Psychiatry, 184, 84 - 85
-
Journal article
Raymont V. et al, (2003), Eur Psychiatry, 18, 13 - 17
-
The Maudsley Bipolar Disorder Project: the effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder.
Journal article
Donaldson S. et al, (2003), J Clin Psychiatry, 64, 86 - 93
-
Journal article
Frangou S. et al, (2002), Bipolar Disord, 4, 378 - 385
-
Journal article
Raymont V., (2002), Psychiatric Bulletin, 26, 201 - 204
-
Journal article
Raymont V., (2001), Psychiatric Bulletin, 25, 46 - 50